for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up
Westlaw News

Takeda loses bid to narrow pay-for-delay case ahead of trial

Takeda Pharmaceutical has lost a bid to limit claims in a case accusing its predecessor Shire Plc of conspiring with generic rival Actavis to delay launch of a generic version of Shire’s ADHD drug Intuniv through illegal patent settlements.

U.S. District Judge Allison Burroughs in Boston on Wednesday denied a motion by Takeda for leave to file a new summary judgment motion that would prevent Intuniv purchasers from arguing that Shire and Actavis could have reached a pro-competitive settlement if they had not cut an illegal deal instead.

To read the full story on Westlaw Today, click here: bit.ly/37dj9Hw

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up